Ventriculoperitoneal shunt in patients with leptomeningeal metastasis
- 10 May 2005
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (9) , 1625-1627
- https://doi.org/10.1212/01.wnl.0000160396.69050.dc
Abstract
The authors reviewed 37 patients with leptomeningeal metastasis (LM) who required a ventriculoperitoneal shunt (VP shunt) for management of intracranial hypertension. Improvement was seen in 27 (77%) patients; subdural hematoma developed in one and shunt malfunction in three. Median overall survival was 2 months (range 2 days to 3.6 years) after VP shunt placement, but there was no procedure-related mortality. The prognosis of LM remained poor, but VP shunt can be an effective palliative tool when required.Keywords
This publication has 5 references indexed in Scilit:
- Leptomeningeal metastasis: survival and prognostic factors in 155 patientsJournal of the Neurological Sciences, 2004
- Ventriculoperitoneal shunt managementPediatric Emergency Care, 2003
- Experience with a programmable valve shunt systemJournal of Neurosurgery, 1999
- Malignancy-Related HydrocephalusAmerican Journal of Clinical Oncology, 1998
- Fabrication and testing of a device capable of reducing the incidence of ventricular shunt promoted metastasisJournal of Neuro-Oncology, 1996